Seelos Therapeutics, Inc(NASDAQ:SEEL) 
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic...
Website: http://www.seelostx.com
Founded: 2016
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-19
P
O 8.32
H 8.80
L 8.16
C 8.80
V 234,524
10EMA 8.80
20EMA 8.80
60EMA 8.80
120EMA 8.80
250EMA 8.80